Pylobactell Europeiska unionen - svenska - EMA (European Medicines Agency)

pylobactell

torbet laboratories ireland limited - urea (13c) - breath tests; helicobacter infections - diagnostiska medel - detta läkemedel är endast för diagnostisk användning. för in vivo-diagnostik av gastroduodenala helicobacter pylori (h. pylori) - infektion.

Norocarp 100 mg Tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

norocarp 100 mg tablett

norbrook laboratories (ireland) limited - karprofen - tablett - 100 mg - natriumlaurilsulfat hjälpämne; tartrazin hjälpämne; laktosmonohydrat hjälpämne; karprofen 100 mg aktiv substans - carprofen - hund

Norocarp vet 100 mg Tuggtablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

norocarp vet 100 mg tuggtablett

norbrook laboratories (ireland) limited - karprofen - tuggtablett - 100 mg - laktosmonohydrat hjälpämne; sackaros hjälpämne; natriumlaurilsulfat hjälpämne; karprofen 100 mg aktiv substans - carprofen - hund

Norocarp vet 20 mg Tuggtablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

norocarp vet 20 mg tuggtablett

norbrook laboratories (ireland) limited - karprofen - tuggtablett - 20 mg - natriumlaurilsulfat hjälpämne; sackaros hjälpämne; laktosmonohydrat hjälpämne; karprofen 20 mg aktiv substans - carprofen - hund

Norocarp vet 50 mg Tuggtablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

norocarp vet 50 mg tuggtablett

norbrook laboratories (ireland) limited - karprofen - tuggtablett - 50 mg - laktosmonohydrat hjälpämne; sackaros hjälpämne; natriumlaurilsulfat hjälpämne; karprofen 50 mg aktiv substans - carprofen - hund

Noroclav Vet 400 mg/100 mg Tablett Sverige - svenska - Läkemedelsverket (Medical Products Agency)

noroclav vet 400 mg/100 mg tablett

norbrook laboratories (ireland) limited - amoxicillintrihydrat; kaliumklavulanat - tablett - 400 mg/100 mg - amoxicillintrihydrat 459 mg aktiv substans; kaliumklavulanat 119,13 mg aktiv substans - amoxicillin och enzymhämmare - hund

Apelka Vet 5 mg/ml Oral lösning Sverige - svenska - Läkemedelsverket (Medical Products Agency)

apelka vet 5 mg/ml oral lösning

norbrook laboratories (ireland) limited - tiamazol - oral lösning - 5 mg/ml - tiamazol 5 mg aktiv substans; glycerol hjälpämne; natriumbensoat hjälpämne - katt

Noroseal 2,6 g Intramammär suspension Sverige - svenska - Läkemedelsverket (Medical Products Agency)

noroseal 2,6 g intramammär suspension

norbrook laboratories (ireland) limited - vismutsubnitrat, tungt - intramammär suspension - 2,6 g - vismutsubnitrat, tungt 2600 mg aktiv substans - Övriga produkter för spenar och juver - nöt

Vetofol vet. 10 mg/ml Injektionsvätska, emulsion Sverige - svenska - Läkemedelsverket (Medical Products Agency)

vetofol vet. 10 mg/ml injektionsvätska, emulsion

norbrook laboratories (ireland) limited - propofol - injektionsvätska, emulsion - 10 mg/ml - propofol 10 mg aktiv substans; sojaolja, raffinerad hjälpämne; glycerol hjälpämne - propofol - hund, katt

Jayempi Europeiska unionen - svenska - EMA (European Medicines Agency)

jayempi

nova laboratories ireland limited - azathioprine - graftförkastning - immunsuppressiva - jayempi is indicated in combination with other immunosuppressive agents for the prophylaxis of transplant rejection in patients receiving allogenic kidney, liver, heart, lung or pancreas transplants. azathioprine is indicated in immunosuppressive regimens as an adjunct to immunosuppressive agents that form the mainstay of treatment (basis immunosuppression). jayempi is used as an immunosuppressant antimetabolite either alone or, more commonly, in combination with other agents (usually corticosteroids) and/ or procedures which influence the immune response. jayempi is indicated in patients who are intolerant to glucocorticosteroids or if the therapeutic response is inadequate despite treatment with high doses of glucocorticosteroids, in the following diseases:severe active rheumatoid arthritis (chronic polyarthritis) that cannot be kept under control by less toxic agents (disease-modifying anti-rheumatic -medicinal products – dmards)auto-immune hepatitis systemic lupus erythematosusdermatomyositispolyarteritis nodosapemphigus vulgaris and bullous pemphigoidbehçet’s diseaserefractory auto-immune haemolytic anaemia, caused by warm igg antibodieschronic refractory idiopathic thrombocytopenic purpurajayempi is used for the treatment of moderately severe to severe forms of chronic inflammatory bowel disease (ibd) (crohn’s disease or ulcerative colitis) in patients in whom glucocorticosteroid therapy is necessary, but where glucocorticosteroids are not tolerated, or in whom the disease is untreatable with other common means of first choice. it is also indicated in adult patients in relapsing multiple sclerosis, if an immunomodulatory therapy is indicated but beta interferon therapy is not possible, or a stable course has been achieved with previous treatment with azathioprine. 3jayempi is indicated for the treatment of generalised myasthenia gravis. depending on the severity of the disease, jayempi should be given in combination with glucocorticosteroids because of slow onset of action at the beginning of treatment and the glucocorticosteroid dose should be gradually reduced after several months of treatment.